KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Financing Activities (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Cash from Financing Activities for 17 consecutive years, with -$6.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 267.17% to -$6.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$10.3 billion, a 301.83% decrease, with the full-year FY2025 number at -$10.3 billion, down 301.83% from a year prior.
  • Cash from Financing Activities was -$6.0 billion for Q4 2025 at Bristol Myers Squibb, down from -$1.5 billion in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $14.6 billion in Q1 2024 to a low of -$7.3 billion in Q1 2021.
  • A 5-year average of -$2.4 billion and a median of -$3.2 billion in 2021 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: tumbled 592.13% in 2021, then surged 580.13% in 2024.
  • Bristol Myers Squibb's Cash from Financing Activities stood at -$4.0 billion in 2021, then grew by 18.17% to -$3.2 billion in 2022, then surged by 129.79% to $967.0 million in 2023, then crashed by 269.8% to -$1.6 billion in 2024, then plummeted by 267.17% to -$6.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Cash from Financing Activities are -$6.0 billion (Q4 2025), -$1.5 billion (Q3 2025), and -$1.8 billion (Q2 2025).